Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference11 articles.
1. Niemeyer CM, Rudelius M, Shimamura A, Flotho C, Hasle H, Stieglitz E, et al. Classification of rare pediatric myeloid neoplasia-Quo vadis? Leukemia. 2022;36:2947–8.
2. Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms. Leukemia. 2022;36:1703–19.
3. Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM, et al. International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022;140:1200–28.
4. Alaggio R, Carneiro F, Chan JKC, Cheung ANY, Cree IA, Denton E, et al. (Eds), WHO Classification of Tumours: Paediatric tumours [Internet; beta version ahead of print]. Lyon (France): International Agency for Research on Cancer; 2022 [cited 2022/11/22]. (WHO Classification of Tumours series, 5th ed.; vol. 7). Available from: https://tumourclassification.iarc.who.int/chapters/44.
5. Strullu M, Caye A, Cassinat B, Fenneteau O, Touzot F, Blauwblomme T, et al. In hematopoietic cells with a germline mutation of CBL, loss of heterozygosity is not a signature of juvenile myelo-monocytic leukemia. Leukemia. 2013;27:2404–7.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献